Syros Pharmaceuticals, Inc.
SYRSDelisted Mar 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001556263
Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in Syros Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 100
- +1 vs. Q2 2021
- Shares held
- 50.1M
- −690.6K (−1.4%) vs. Q2 2021
- Total value
- $223.1M
- −$52.5M (−19.1%) vs. Q2 2021
- New holders
- 16
- 29 more added
- Sold out
- 15
- 34 more reduced
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 7 | $12.4K |
| Q4 2024 | 44 | $1.20M |
| Q3 2024 | 65 | $40.8M |
| Q2 2024 | 70 | $105.2M |
| Q1 2024 | 75 | $111.9M |
| Q4 2023 | 58 | $146.8M |
| Q3 2023 | 48 | $47.9M |
| Q2 2023 | 53 | $33.5M |
| Q1 2023 | 59 | $27.5M |
| Q4 2022 | 57 | $37.9M |
| Q3 2022 | 53 | $59.9M |
| Q2 2022 | 69 | $34.2M |
| Q1 2022 | 94 | $53.1M |
| Q4 2021 | 90 | $166.0M |
| Q3 2021 | 100 | $223.1M |
| Q2 2021 | 100 | $276.0M |
| Q1 2021 | 106 | $475.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −354,453−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −82,200−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −78,774−100.0% | Sold out |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −65,497−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −27,860−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −26,018−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −23,348−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −13,905−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −12,826−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Capital Advisory Group Advisory Services, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −428−100.0% | Sold out |
| QS Investors, LLC | – | – | – | – | Not filed |